ArticleAntimicrobial agents and chemotherapy2008

Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model.

Selwyn J Hurwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.